Trial Profile
A Multi-center Study for the Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Jan 2022
Price :
$35
*
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease
- Focus Pharmacogenomic; Therapeutic Use
- Sponsors Eisai Korea
- 13 Jul 2010 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 07 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Jan 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.